secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001493152-25-010716
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $33K convertible note to GS Capital Partners for working capital
--------------------------------------------------------------------------------

- Convertible promissory note with $33,000 principal, purchased at $30,000 (original issue discount of $3,000).
- Conversion price initially $6.00/share, drops to $3.00 if stock trades below $5.00 for 5 consecutive days.
- Note matures Nov 11, 2025, bears 8% interest; prepayment allowed at 110%-125% premiums within first 180 days.
- Proceeds from the private placement will be used for general working capital purposes.
- Issued to GS Capital Partners, LLC in reliance on Regulation D exemption under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225010716/0001493152-25-010716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225010716/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer